BioTechX Europe 2026 Exhibitors
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
143 organizations exhibit at BioTechX Europe 2026 — 129 technology and service providers, 10 drug developers and 4 academic, government and non-profit bodies. 60 of them also present on the scientific program, with 93 presentations between them. Most represented: Novo Nordisk (13 on the program), Seqera (3 on the program), Elsevier (3 on the program). 143 of them have their own page in this guide. As of Sep 26, 2026.
Topic
Top represented
Showing 1–30 of 143 organizations
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Novo Nordisk Bagsværd, Denmark | |
Danish pharmaceutical company making medicines for diabetes, obesity and rare blood and endocrine diseases. | Booth Exhibiting (no floor booth listed) Keynote Tue Oct 6 09:40 The use of agentic AI in R&D AI & large language models Talk Tue Oct 6 11:45 Talk Tue Oct 6 16:10 Panel Tue Oct 6 17:25 Build, Buy, or Partner: From Agentic AI Hype to Enterprise Value How drug companies should choose between building, buying or partnering for AI that acts on its own, and how to oversee it. Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Gaining a competitive advantage in drug discovery through linked, multi-dimensional data at scale What it takes to build large, well-labeled genome and cell datasets for AI drug discovery, and to link different datasets together. Chair Wed Oct 7 11:40 Talk Wed Oct 7 13:05 Talk Wed Oct 7 16:30 Panel Wed Oct 7 17:25 Panel Wed Oct 7 17:25 Panel Wed Oct 7 17:25 Talk Thu Oct 8 12:10 |
Seqera Barcelona, Spain | |
Software for scalable, reproducible scientific data analysis pipelines in genomics and beyond. | Booth Exhibiting at Booth 420 Chair Tue Oct 6 11:40 Talk Tue Oct 6 15:50 |
Elsevier Amsterdam, Netherlands | |
Scientific and health information company offering evidence-based content and AI-enabled digital tools for pharmaceutical and biotech R&D. | Booth Exhibiting at Booth 328 Keynote Tue Oct 6 09:20 Semantic Layer or Silent Failure: Evidence-Based Rules for Grounding Agentic Workflows in Drug Discovery AI & large language modelsData integration & FAIR Talk Tue Oct 6 12:05 Making agentic workflows in drug discovery dependable with chemistry, pharmacokinetics, and safety data connectors How cleaned, consistently labeled data on chemistry, safety and how the body processes drugs makes AI drug discovery assistants more dependable. |
EPAM Newtown, PA | |
Software engineering and consulting firm whose life sciences practice builds data, AI and clinical platforms for pharma. | Booth Exhibiting at Booth 424 Talk Tue Oct 6 12:45 Beyond Trials: Engineering an AI-Driven Self-Synchronizing Clinical Data Hub How a clinical trial data platform updates its data feeds automatically when agreements with outside data suppliers change, keeping a full record. Talk Wed Oct 7 09:50 AI at Scale: Charting the Future of Pharmaceutical Innovation How drug companies can move from one-off AI projects to company-wide use, including data systems, staff buy-in and ethical rules. AI & large language models |
Enterprise IT company supplying supercomputing, AI and data platforms, including for biotech and pharma research. | Booth Exhibiting at Booth 226 Panel Wed Oct 7 17:25 Talk Thu Oct 8 11:30 |
Non-profit consortium developing open interoperability standards for laboratory instruments and data. | Booth Exhibiting at Booth 341 Talk Tue Oct 6 16:50 From FAIR to Interoperability: How Open Standards Unlock Scalable Data Integration in the Lab How open standards, developed by a non-profit group of lab users and suppliers, let instruments and software from different makers share data. Panel Tue Oct 6 17:25 |
UK health research programme recruiting up to 5 million adults, with over 2.8 million participants so far. | Booth Exhibiting at Booth 421 Talk Tue Oct 6 15:50 Chair Wed Oct 7 11:40 Chair Wed Oct 7 15:25 Chair Wed Oct 7 15:25 Keynote Thu Oct 8 13:20 |
Illumina San Diego, CA | |
Sequencing company that also offers linked, multi-dimensional genomic data at scale for drug discovery. | Booth Exhibiting at Booth 422 Chair Tue Oct 6 11:40 Panel Tue Oct 6 17:25 Gaining a competitive advantage in drug discovery through linked, multi-dimensional data at scale What it takes to build large, well-labeled genome and cell datasets for AI drug discovery, and to link different datasets together. |
Sample-to-insight company; here its QIAGEN Digital Insights unit shows curated biomedical knowledge bases and omics analysis software. | Booth Exhibiting at Booth 358 Talk Tue Oct 6 12:05 From Causal Knowledge Graphs to Cell-Level Predictions of Biological Activity in Single Cell and Spatial Datasets How curated cause-and-effect facts about gene regulation can predict pathway activity in each single cell, revealing cell groups that standard grouping methods miss. Talk Wed Oct 7 16:50 The evidence foundation that delivers AI agents with the best accuracy and scalability Testing AI models on drug discovery tasks alone versus linked to curated networks of biological facts, comparing accuracy, sourcing and cost. |
Digital services partner for life sciences and healthcare, offering AI, data science and software engineering. | Booth Exhibiting at Booth 190 Talk Wed Oct 7 16:10 Talk Wed Oct 7 16:30 |
SAS Cary, NC | |
Analytics and AI software used by pharma and biotech across clinical research and development. | Booth Exhibiting at Booth 290 Panel Tue Oct 6 17:25 Talk Wed Oct 7 12:05 Orchestrating the Future of Clinical R&D: From Long-established Expertise to AI‑Driven Expert Agents How specialist AI assistants for data handling, statistics and reporting could reshape clinical research work, with human experts directing them. |
Wiley Hoboken, NJ | |
Scientific publisher providing research content and data to life sciences organizations. | Booth Exhibiting at Booth 202 Panel Tue Oct 6 17:25 |
ZS Evanston, IL | |
Management consulting and technology firm providing analytics, data and AI services to pharma and life sciences. | Booth Exhibiting at Booth 326 Talk Tue Oct 6 16:30 |
 Amazon Web Services Seattle, WA | |
Amazon's cloud computing business, offering compute, storage and AI services including AWS HealthOmics for genomics. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 6 15:50 Self-Service Bioinformatics at Scale with AWS HealthOmics and Kiro How AI tools let scientists set up, run and troubleshoot their own cloud-based sequencing analyses in hours rather than months. |
High-performance computing and AI infrastructure for genomics, drug discovery and research workloads, combining compute, storage and accelerated hardware. | Booth Exhibiting at Booth 292 |
Causaly London, United Kingdom | |
AI platform for biomedical research that maps cause-and-effect relationships from scientific literature and data for drug discovery teams. | Booth Exhibiting (no floor booth listed) Talk Wed Oct 7 12:45 |
Certara Radnor, PA | |
Biosimulation software and services for drug development, including modelling, simulation and scientific informatics. | Booth Exhibiting at Booth 288 |
EL | |
Platform bringing policy enforcement, cryptographic traceability and verifiable audit evidence to AI and agentic workflows in life sciences. | Booth Exhibiting at Booth S48 Talk Thu Oct 8 11:10 When Regulators Come Knocking: Building Agentic AI That Can Answer AI & large language models |
Flywheel Minneapolis, MN | |
Imaging data platform that curates, manages and prepares medical and research imaging data for AI across the R&D pipeline. | Booth Exhibiting at Booth 204 Talk Wed Oct 7 12:05 The Imaging Data Factory: Activating Imaging Data Across the Full R&D Pipeline How one platform automatically turns scattered medical imaging data into traceable, compliant datasets ready for clinical trial analysis and AI training. |
Booth Exhibiting at Booth 438 Talk Tue Oct 6 12:45 | |
Booth Exhibiting at Booth S6 | |
Digital Science London, United Kingdom | |
AI-focused technology company providing research data, analytics and collaboration tools to knowledge workers in research-intensive industries. | Booth Exhibiting at Booth 278 Talk Tue Oct 6 12:05 The Foundation for Trustworthy AI: From FAIR Data Principles to Enterprise-Ready AI in Pharma How drug companies can build trustworthy AI by making data findable and reusable, and linking facts together so answers can be checked. Talk Tue Oct 6 15:50 A Practical Path to AI-Grounded Drug Discovery with Knowledge Graphs How pairing large language models with networks of known biological facts makes them more reliable at finding drug targets and predicting drug interactions. |
Server, storage and AI infrastructure supplier working with NVIDIA on AI for drug discovery, research and data-intensive analytics. | Booth Exhibiting at Booth 410 Chair Tue Oct 6 11:40 Talk Tue Oct 6 12:45 Accelerating Drug Discovery with AI: Hybrid AI Innovation Across Public and Private Environments How drug companies train AI models centrally but run them locally, across public and private computing systems, to analyze sensitive research data faster. |
Nebius Amsterdam, Netherlands | |
AI cloud providing GPU and high-performance computing infrastructure for drug discovery, genomics, imaging and digital health. | Booth Exhibiting at Booth 430 Chair Wed Oct 7 11:40 |
Neo4j San Mateo, CA | |
Graph database and knowledge graph platform that connects fragmented data for analytics and AI. | Booth Exhibiting at Booth 216 Talk Tue Oct 6 12:45 Augmented AI: Building Contextual Intelligence with Knowledge Graphs How knowledge graphs, databases of linked facts, help large language models give more accurate answers with fewer made-up claims in drug research. Talk Thu Oct 8 11:50 HepSAFE: Integrating Clinical, Literature, and Experimental Evidence for DILI Prediction How linking clinical, published and lab evidence in one connected database helps predict which drug candidates may injure the liver. |
ALLOX Barcelona, Spain | |
Combines systematic mutagenesis, high-throughput phenotyping and biophysical modelling to map protein function and develop better drugs. | Booth Exhibiting at Booth S19 Talk Thu Oct 8 12:10 Mapping therapeutic hotspots at scale to develop better drugs Bioinformatics & cheminformatics |
Ardigen Kraków, Poland | |
AI-driven computational partner helping biotech and pharma teams with data- and AI-enabled drug discovery. | Booth Exhibiting at Booth 282 Talk Tue Oct 6 12:05 Enabling AI for modern drug discovery: from multimodal data to target and further How tidied data, a database of linked biological facts and AI helpers turn scattered research records into traceable choices of drug targets. |
Delivers strategies and solutions to life sciences companies, combining specialist people, proven processes and technology. | Booth Exhibiting at Booth 220 Talk Tue Oct 6 12:05 The AI-Readiness Gap: Why Most Lab Data Isn't Fit for Machine Learning (and How to Fix It) Why AI projects in drug research stall when lab data was never set up for them, and a practical way to fix that. |
Benchling San Francisco, CA | |
Cloud software for biotech R&D, including electronic lab notebook, registry and data tools. | Booth Exhibiting at Booth 206 Talk Wed Oct 7 12:45 AI for Every Scientist: How Agentic AI, Grounded in the Scientific Record, Accelerates Discovery How AI assistants built into a lab data platform can draft hypotheses, write reports and flag expiring reagents while citing their sources. |
Biorelate Manchester, United Kingdom | |
Causal AI platform that curates cause-and-effect relationships from biomedical literature to support drug discovery. | Booth Exhibiting at Booth 426 Talk Tue Oct 6 12:45 |
Instantly find 20 buyers from BioTechX Europe 2026 exhibitors
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse BioTechX Europe 2026 by
Organization type
Topic
Exhibit hall
- Exhibitors 143
Everyone
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction